Results 111 to 120 of about 189,515 (386)

Real‐life retrospective multicentre study to describe the use of dupilumab in paediatric patients with atopic dermatitis in Spain: Patient profile, effectiveness and safety

JEADV Clinical Practice, EarlyView.
Abstract Background Dupilumab, inhibiting interleukin 4 and 13, is the first monoclonal antibody licensed for atopic dermatitis (AD) since 6 months of age. Objectives The study describes the patients' profile, the effectiveness and safety in real life of dupilumab in adolescents with moderate‐severe AD and children with severe AD.
Eulalia Baselga Torres, Marta Ivars, Carolina Prat, Asunción Vicente, Marta Feito Rodríguez, Rocío Maseda Pedrero, Ana Martín Santiago, Aniza Giacaman, Antonio Torrelo Fernández, Lucero Noguera‐Morel, Isabel Betlloch Mas, Laura de Berbegal Gracia, Montserrat Évole Buselli, Mónica Pozuelo Ruiz, José Bernabéu Wittel, María T. Monserrat García, Minia Campos Domínguez, Cristina Galache Osuna, Jorge Santos‐Juanes Jiménez, Altea Esteve Martínez, Violeta Zaragoza Ninet, Miquel Casals Andreu, Sara I. Palencia Pérez, José Suárez Hernández, Sara Dorta Alom, Laura Feliciano Divasson, Ana Batalla Cebey, Manuel Galán Gutiérrez, Raúl de Lucas Laguna   +28 more
wiley   +1 more source

How has the COVID‐19 pandemic affected eczema self‐management and help seeking? A qualitative interview study with young people and parents/carers of children with eczema

Skin Health and Disease, 2021
Background Eczema can have a considerable impact on quality of life. Treatments can improve this, but management is complex. Barriers to eczema self‐management may be impacted upon by environmental context, such as the COVID‐19 pandemic.
M. Steele, L. Howells, M. Santer, K. Sivyer, S. Lawton, A. Roberts, E. Teasdale, I. Muller, K. Greenwell   +8 more
doaj   +1 more source

Role of genetic aspect in pathogenesis of atopic dermatitis [PDF]

, 2013
The pathogenesis of atopic dermatitis (AD) is a very complicated process that involves an intricate array of molecules. Nowadays it is generally accepted that cytokines play an important role in the progression of the clinical presentation of atopic ...
Wesserling Martyna
core   +1 more source

Reliable Detection of Eczema Areas for Fully Automated Assessment of Eczema Severity from Digital Camera Images

JID Innovations, 2023
Assessing the severity of eczema in clinical research requires face-to-face skin examination by trained staff. Such approaches are resource-intensive for participants and staff, challenging during pandemics, and prone to inter- and intra-observer ...
Rahman Attar, Guillem Hurault, Zihao Wang, Ricardo Mokhtari, Kevin Pan, Bayanne Olabi, Eleanor Earp, Lloyd Steele, Hywel C. Williams, Reiko J. Tanaka   +9 more
doaj  

THE ETIOLOGY OF ECZEMA [PDF]

Archives of Dermatology, 1920
THREE THEORIES CONCERNING ETIOLOGY OF ECZEMA The history of the early views held concerning the etiology of eczema has been well given by both Brocq1and Besnier.2These views, as well as those of more recent times, are admirably summarized in an excellent article by Highman.3The opinions of various men and of various schools are widely diverse and are ...
openaire   +2 more sources

Patient‐Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement

British Journal of Dermatology, 2017
The Harmonising Outcome Measures for Eczema (HOME) initiative has defined four core outcome domains for a core outcome set (COS) to be measured in all atopic eczema (AE) trials to ensure cross‐trial comparison: clinical signs, symptoms, quality of life ...
P. Spuls, L. Gerbens, E. Simpson, C. Apfelbacher, Joanne R Chalmers, Kim S Thomas, C. Prinsen, L. Kobyletzki, J. A. Singh, J. A. Singh, H. C. Williams, J. Schmitt   +11 more
semanticscholar   +1 more source

Patients’ and Caregivers’ Experiences Navigating the Burden of Atopic Dermatitis in Argentina

Medicina
Background and Objectives: Little is known about patients’ and caregivers’ experiences with atopic dermatitis (AD) in Argentina, so a survey was administered to learn more.
Korey Capozza, Michelle Tu, Alan Schwartz, Jodi L. Johnson, Mónica Ladner   +4 more
doaj   +1 more source

Debates in allergy medicine: Specific immunotherapy in children with atopic dermatitis, the "con" view. [PDF]

, 2016
Atopic dermatitis (AD) is a common chronic skin condition in children that has a proven association with other atopic conditions and allergies. These associations, like the general pathophysiology of AD, are complex and not fully understood.
Eichenfield, Lawrence F, Ginsberg, David N   +1 more
core   +3 more sources

Hand eczema: treatment

Journal of the European Academy of Dermatology and Venereology, 2019
Hand eczema is a highly prevalent, multietiological disease with a wide spectrum of severity and chronicity. The treatment of hand eczema, especially in severe and chronic cases, is a challenge to the dermatologist requiring not only diagnostic and ...
P. Elsner, T. Agner
semanticscholar   +1 more source

Lack of Evidence for the Efficacy of Antifungal Medications to Treat Atopic Dermatitis: A Systematic Review

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Atopic dermatitis (AD) is characterised by immune dysregulation and skin‐barrier dysfunction, which can predispose to microbial dysbiosis and skin infections. Fungi, particularly Malassezia, are common skin colonisers in AD patients and may exacerbate the condition.
Luis F. Andrade, Teresa Ju, Parsa Abdi, Michael R. Anderson, Elise Edwards, Nicole Khalil, Olivia Burke, Daniella Jaguan, Jonathan I. Silverberg   +8 more
wiley   +1 more source